HCPCS Service Codes - Medical care

HCPCS Codes for Medical care

• G9612

  Photodocumentation of two or more cecal landmarks to establish a complete examination

• G9613

  Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)

• G9614

  Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examination

• G9615

  Preoperative assessment documented

• G9616

  Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)

• G9617

  Preoperative assessment not documented, reason not given

• G9618

  Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kind

• G9619

  Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)

• G9620

  Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not given

• G9621

  Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling

• G9622

  Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method

• G9623

  Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)

• G9624

  Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user

• G9625

  Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery

• G9626

  Documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury)

• G9627

  Patient did not sustain bladder injury at the time of surgery nor discovered subsequently up to 30 days post-surgery

• G9628

  Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days post-surgery

• G9629

  Documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury)

• G9630

  Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery

• G9631

  Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgery

• G9632

  Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)

• G9633

  Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgery

• G9634

  Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improved

• G9635

  Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire)

• G9636

  Health-related quality of life not assessed with tool during at least two visits or quality of life score declined

• G9637

  Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

• G9638

  Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)

• G9639

  Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedure

• G9640

  Documentation of planned hybrid or staged procedure

• G9641

  Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedure

• G9642

  Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)

• G9643

  Elective surgery

• G9644

  Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure

• G9645

  Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure

• G9646

  Patients with 90 day mrs score of 0 to 2

• G9647

  Patients in whom mrs score could not be obtained at 90 day follow-up

• G9648

  Patients with 90 day mrs score greater than 2

• G9649

  Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))

• G9650

  Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

• G9651

  Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented

• G9652

  Patient has been treated with a systemic or biologic medication for psoriasis for at least six months

• G9653

  Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months

• G9654

  Monitored anesthesia care (mac)

• G9655

  A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used

• G9656

  Patient transferred directly from anesthetizing location to pacu or other non-icu location

• G9657

  Transfer of care during an anesthetic or to the intensive care unit

• G9658

  A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used

• G9659

  Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits

• G9660

  Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)

• G9661

  Patients greater than or equal to 86 years of age who received a colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions